Loading organizations...
Sienna Biopharmaceuticals has raised $86.0M across 3 funding rounds.
Sienna Biopharmaceuticals has raised $86.0M in total across 3 funding rounds.
Sienna Biopharmaceuticals has raised $86.0M in total across 3 funding rounds.
Sienna Biopharmaceuticals's investors include ARCH Venture Partners, Venvest Capital, David Pyott, Altitude Life Science Ventures, Fidelity Management & Research Company, Omega Funds, Partner Fund Management, Two River, Kristina Burow.
Sienna Biopharmaceuticals has raised $86.0M across 3 funding rounds. Most recently, it raised $40.0M Series B in April 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 24, 2017 | $40M Series B | ARCH Venture Partners, Venvest Capital | David Pyott, Altitude Life Science Ventures, Fidelity Management & Research Company, Omega Funds, Partner Fund Management | Announced |
| Jul 12, 2016 | $12M Series A Plus | ARCH Venture Partners, Partner Fund Management | Altitude Life Science Ventures, TWO River, Venvest Capital | Announced |
| Apr 28, 2016 | $34M Series A | Kristina Burow | Altitude Life Science Ventures, Partner Fund Management, Venvest Capital | Announced |
